Characterization of the murine cyclin-dependent kinase inhibitor gene p27(Kip1)

被引:62
|
作者
Kwon, TK [1 ]
Nagel, JE [1 ]
Buchholz, MA [1 ]
Nordin, AA [1 ]
机构
[1] NIA,CLIN IMMUNOL SECT,GERONTOL RES CTR,NATL INST HLTH,BALTIMORE,MD 21224
关键词
cell cycle; T-cell; cdk inhibitor; promoter; cyclin; transcription factors;
D O I
10.1016/S0378-1119(96)00416-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The cyclin-dependent kinase inhibitor p27(Kip1) plays an important role in regulating cell-cycle progression. p27(Kip1) directly inhibits the catalytic activity of cyclin/cdks (cyclin-dependent kinase) complexes and/or interferes physically with cyclin/cdks activation by CAK. Interestingly, the expression level of p27(Kip1) mRNA was maximal in resting G(0) T-cells and rapidly declined following anti-CD3 activation. We report here the cloning of p27(Kip1) gene from murine genomic DNA and the functional analysis of the promoter of the p27(Kip1) gene. The gene consists of at least three exons and spans more than 5.6 kb of DNA. Primer extension and nuclease S1 protection analysis revealed two major transcription initiation sites. The promoter region lacked a TATA box but contained potential binding sites for the transcriptional factors including two Spl, CRE, Myb and NFkB located at positions -153, -178, -286, -875, and -1011, respectively. To analyze the regulatory mechanisms controlling p27(Kip1) gene expression, we characterized the 5'-flanking region from nt -1609 to +178. The -326 to -615 region contained positive regulatory elements.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 50 条
  • [31] The cyclin-dependent kinase inhibitor p27Kip1 is localized to the cytosol in Swiss/3T3 cells
    Gang Wang
    Robin Miskimins
    W Keith Miskimins
    Oncogene, 1999, 18 : 5204 - 5210
  • [32] The expression of human epididymis protein 4 and cyclin-dependent kinase inhibitor p27Kip1 in human ovarian carcinoma
    Lu, Mudan
    Zhou, Jianbo
    Xu, Fei
    Yin, Yongxiang
    Chen, Daozhen
    ASIAN BIOMEDICINE, 2011, 5 (06) : 765 - 773
  • [33] Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in human colon cancer
    Sgambato, A
    Ratto, C
    Faraglia, B
    Merico, M
    Ardito, R
    Schinzari, G
    Romano, G
    Cittadini, ARM
    MOLECULAR CARCINOGENESIS, 1999, 26 (03) : 172 - 179
  • [34] The Cyclin-Dependent Kinase Inhibitor p27kip1 Regulates Radial Stem Cell Quiescence and Neurogenesis in the Adult Hippocampus
    Andreu, Zoraida
    Khan, Muhammad Amir
    Gonzalez-Gomez, Pilar
    Negueruela, Santiago
    Hortigueela, Rafael
    Emeterio, Juana San
    Ferron, Sacri R.
    Martinez, Gloria
    Vidal, Anxo
    Farinas, Isabel
    Lie, Dieter Chichung
    Mira, Helena
    STEM CELLS, 2015, 33 (01) : 219 - 229
  • [35] The cyclin-dependent kinase inhibitor p27Kip1 interacts with the aryl hydrocarbon receptor and negatively regulates its transcriptional activity
    Elson, Daniel J.
    Nguyen, Bach D.
    Wood, Rhand
    Zhang, Yi
    Puig-Sanvicens, Veronica
    Kolluri, Siva K.
    FEBS LETTERS, 2022, 596 (16) : 2056 - 2071
  • [36] The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression
    Xia, ZB
    Popovic, R
    Chen, J
    Theisler, C
    Stuart, T
    Santillan, DA
    Erfurth, F
    Diaz, MO
    Zeleznik-Le, NJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (39) : 14028 - 14033
  • [37] Myc activation of cyclin E Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes
    PerezRoger, I
    Solomon, DLC
    Sewing, A
    Land, H
    ONCOGENE, 1997, 14 (20) : 2373 - 2381
  • [38] The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer
    Chiarle R.
    Pagano M.
    Inghirami G.
    Breast Cancer Research, 3 (2) : 91 - 94
  • [39] The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer
    Chiarle, R
    Pagano, M
    Inghirami, G
    BREAST CANCER RESEARCH, 2001, 3 (02): : 91 - 94
  • [40] HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways
    Le, XF
    Pruefer, F
    Bast, RC
    CELL CYCLE, 2005, 4 (01) : 87 - 95